| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 01/29/2014 | CN101600730B Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 01/29/2014 | CN101448850B Immunomodulating oligopeptides |
| 01/28/2014 | US8637635 Peptides that selectively home to heart vasculature and related conjugates and methods |
| 01/28/2014 | US8637463 Peptide inhibiting angiotensin converting enzyme |
| 01/28/2014 | US8636977 Integrin targeted synthetic ligands for diagnostic and therapeutic applications |
| 01/28/2014 | CA2568008C Process for preparing acyclic hcv protease inhibitors |
| 01/23/2014 | WO2014013272A1 Rhodamine based fluorescent probe for coagulase activity and detection of coagulase producing bacterial strains |
| 01/23/2014 | WO2013184962A4 Chimeric fibroblast growth factor 19 proteins and methods of use |
| 01/23/2014 | US20140024804 Crystalline Tripeptide Epoxy Ketone Protease Inhibitors |
| 01/23/2014 | US20140024803 18fdg multimeric positron emission tomography imaging agents |
| 01/23/2014 | US20140023616 Macrocyclic inhibitors of flaviviridae viruses |
| 01/22/2014 | EP2686337A1 Oligopeptides and process for preparation thereof |
| 01/22/2014 | EP2686336A1 N-carboxyalkyl-auristatins and use thereof |
| 01/22/2014 | CN103524598A Cyclic peptide compound and preparation method thereof as well as medicinal composition and application thereof |
| 01/22/2014 | CN103524597A Antioxidant peptide prepared from shark prolamin and preparation method and application thereof |
| 01/22/2014 | CN103524596A Antioxidative peptide of shark protein as well as preparation method and use thereof |
| 01/22/2014 | CN103524595A Method for synthesizing pseudo-dipeptide Fmoc-Gly-Thr(phiMe, Me pro)-OH by utilizing new kilogram method |
| 01/22/2014 | CN103524506A Preparation method and application of radioiodine labeled biomolecules |
| 01/22/2014 | CN103524391A Method for co-producing astaxanthin and glutathione |
| 01/22/2014 | CN102796164B Kyotorphin modified fatty amine/alcohol derivative, and preparation method and application thereof |
| 01/22/2014 | CN102241735B Polypeptide used for prevention and treatment of acute coronary syndrome and anticoagulation antithrombotic therapy and application thereof |
| 01/21/2014 | US8633224 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 01/21/2014 | US8633163 Template-fixed peptidomimetics |
| 01/21/2014 | US8633158 Angiotensin in treating brain conditions |
| 01/21/2014 | US8632992 Methods for assaying enzyme activities |
| 01/21/2014 | CA2650578C Cosmetic composition for stimulating the synthesis of proteins of the basement membrane |
| 01/16/2014 | WO2014010755A1 Dna encoding bacterial l-amino acid alpha-ligases and use thereof for producing dipeptides |
| 01/16/2014 | WO2014010721A1 Method of producing self-assembling peptide derivative |
| 01/16/2014 | WO2014010700A1 Amino compound, high-sensitivity mass spectrometry method for same, and method for assaying for biomarker |
| 01/16/2014 | WO2014009774A1 Conjugates of cell binding molecules with cytotoxic agents |
| 01/16/2014 | US20140018545 Inhibitors of Dipeptidylpeptidase IV |
| 01/16/2014 | US20140018518 Crystaline forms of hcv inhibitor |
| 01/16/2014 | US20140018303 3-Amino-2-Hydroxy-4-Phenylbutanoyl-Valyl-Isoleucine, Preparation and Use Thereof |
| 01/16/2014 | US20140018301 Boronate ester compounds and pharmaceutical compositions thereof |
| 01/16/2014 | US20140018294 Neurogenic brain-derived neurotrophic factor peptides |
| 01/15/2014 | CN103509085A Conjugate of androstane and RGD, synthesis thereof, anti-osteoporosis activity thereof, and application thereof |
| 01/15/2014 | CN103509084A Preparation method of argatroban |
| 01/15/2014 | CN103509083A Broad-spectrum beta-lactamase fluorescent substrate, and preparation method and application thereof |
| 01/15/2014 | CN102690325B Synthesis of polypeptide PyroGlu-Pro-Arg-pNA.HCl |
| 01/15/2014 | CN102603866B Oligopeptide-based pH-sensitive amphoteric ion and application thereof in medicament |
| 01/15/2014 | CN102250203B Beta-carboline aminoacid benzyl ester, preparation method and application thereof |
| 01/15/2014 | CN102177173B Collagen peptide, dipeptide, and agent for prevention of disease |
| 01/15/2014 | CN102124346B Thrombin substrate and assay for determining the level of bioactive thrombin in a sample |
| 01/15/2014 | CN102098923B Lactobacillus helveticus strains for producing hypotensive peptides |
| 01/14/2014 | US8629241 Alpha helical mimics, their uses and methods for their production |
| 01/09/2014 | WO2013151467A3 Method for producing a recombinant peptide and resultant peptide |
| 01/09/2014 | WO2013132317A9 Peptidomimetic compounds as immunomodulators |
| 01/09/2014 | US20140011259 Protein Variants Having Modified Immunogenicity |
| 01/09/2014 | US20140010784 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/08/2014 | CN103502215A Prodrugs of D-gamma-glutamyl-D-tryptophan and D-gamma- glutamyl-L-tryptophan |
| 01/08/2014 | CN103502214A Prodrugs of D-isoglutamyl-[D/L]-tryptophan |
| 01/08/2014 | CN103497985A Walnut protein antioxidant peptides and preparation method thereof |
| 01/08/2014 | CN103497234A Telaprevir intermediate crystal form-A and synthesis method thereof |
| 01/08/2014 | CN103497233A Preparation method for bortezomib |
| 01/08/2014 | CN103497232A Boronate ester compounds and pharmaceutical compositions thereof |
| 01/08/2014 | CN103497210A Boronate ester compounds and pharmaceutical compositions thereof |
| 01/08/2014 | CN103495162A Preparation method of porcine reproductive and respiratory syndrome compound inactivated vaccine |
| 01/08/2014 | CN102796167B (S)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine-6-formyl-L-prolyl-L-alanyl-L-amino acid, and preparation method and application thereof |
| 01/07/2014 | US8623995 Peptide conjugates and fluorescence detection methods for intracellular caspase assay |
| 01/07/2014 | US8623828 Blocking mesothelin peptide fragments |
| 01/07/2014 | US8623378 Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
| 01/03/2014 | WO2014002571A1 Angiotensin-converting-enzyme inhibiting dipeptide |
| 01/02/2014 | US20140005359 Branched chain-containing aromatic compound |
| 01/02/2014 | US20140005121 Oligopeptides and process for preparation thereof |
| 01/02/2014 | US20140005104 Polyheterocyclic compounds highly potent as hcv inhibitors |
| 01/02/2014 | US20140004039 RGD MIMETIC y-AAPEPTIDES AND METHODS OF USE |
| 01/02/2014 | CA2820547A1 Rgd mimetic y-aapeptides and methods of use |
| 01/01/2014 | CN103483421A Polypeptide used for treating HBV infection and related diseases, and antibodies thereof |
| 01/01/2014 | CN103483420A Telaprevir intermediate in B crystal form and synthesis method thereof |
| 01/01/2014 | CN103483419A Telaprevir intermediate in crystal form C, and synthesis method thereof |
| 01/01/2014 | CN103483117A Method for producing compound |
| 01/01/2014 | CN102164928B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 12/31/2013 | US8618324 Composition and method for making oligo-benzamide compounds |
| 12/31/2013 | US8618249 Peptides having an ACE inhibiting effect |
| 12/31/2013 | US8618248 Phosphopeptide compositions and anti-phosphopeptide antibody compositions and methods of detecting phosphorylated peptides |
| 12/31/2013 | CA2599291C Compounds for reducing aggregation of amyloid beta-peptide |
| 12/31/2013 | CA2426030C Methods of treating disorders related to apoe |
| 12/27/2013 | WO2013191926A1 Synthesis of beta-turn peptidomimetic cyclic compounds |
| 12/27/2013 | WO2013189978A1 PROCESS FOR PREPARING ß-AMINO ACID DERIVATIVES AND USE OF SAID PROCESS FOR PREPARING TELAPREVIR |
| 12/26/2013 | US20130345155 Modulators for sirt6 and assays for screening same |
| 12/26/2013 | US20130345123 Substituted adipic acid amides and uses thereof |
| 12/26/2013 | US20130345120 Peptide deformylase inhibitors |
| 12/26/2013 | US20130345117 Peptide-phospholipid conjugates |
| 12/26/2013 | US20130344030 Macrocyclic inhibitors of flaviviridae viruses |
| 12/26/2013 | US20130344029 Macrocyclic inhibitors of flaviviridae viruses |
| 12/26/2013 | US20130344026 Dimeric Smac Mimetics |
| 12/25/2013 | EP2676683A1 Material for tissue regeneration, aqueous protein solution containing same, and method for gelling same |
| 12/25/2013 | EP2675814A1 Haprolid and derivatives thereof as inhibitors of hcv |
| 12/25/2013 | EP2173707B1 Pleuromutilin derivatives and their use as antimicrobials |
| 12/25/2013 | CN103467588A Stabilized alpha helical peptides and uses thereof |
| 12/25/2013 | CN103467567A Chemical synthesis method for furan allyl fluorescent dipeptide metalloproteinases substrate |
| 12/25/2013 | CN103467566A Method for synthesizing novel pseudo dipeptide at kilogram level |
| 12/25/2013 | CN103467565A Boronate ester compounds and pharmaceutical compositions thereof |
| 12/25/2013 | CN103030681B Forced-induced fluorescence color-changing compound and preparation method and application thereof |
| 12/25/2013 | CN102603868B Synthetic polypeptide and application of synthetic polypeptide |
| 12/25/2013 | CN102557989B Ulimorelin intermediate and Ulimorelin preparation method |
| 12/25/2013 | CN102453077B Fluoronosiheptide and preparation method and application thereof |
| 12/25/2013 | CN102372765B Preparation method of ruditapes philippinarum enzymatic polypeptide |
| 12/25/2013 | CN102286105B Sesame protein source metal chelating peptide and peptide trace element chelate and application thereof |
| 12/24/2013 | US8614289 Processes for the manufacture of macrocyclic depsipeptides and new intermediates |